Management Sciences for Health Selected by USAID to Support Global Health Supply Chains

Arlington, VA—January 4, 2024— Management Sciences for Health (MSH) announced today that it has been selected by USAID as a winner of the Global Health Supply Chain NextGen Comprehensive Technical Assistance contract. This indefinite delivery, indefinite quantity (IDIQ) contract award means that MSH is one of five large organizations that will partner with USAID to provide countries with technical assistance on their supply chain needs for the next 10 years. Under this contract, MSH and its consortium partners can work with countries to develop the capacity of local systems, networks, institutions, and individuals to sustainably manage supply chains and strengthen local pharmaceutical systems. MSH can also advise governments as they shift from providing supply chain and pharmaceutical services themselves to overseeing private-sector innovations and efficiencies.

Since the early 1990s, MSH has partnered with governments and the private sector across dozens of countries in supply chain and pharmaceutical system strengthening to ensure access to safe, quality-assured, affordable medicines and health technologies. MSH’s 2023–2030 strategy maps out how the organization’s work will contribute to the achievement of the Sustainable Development Goals. The strategy prioritizes supporting local leaders to develop resilient, people-centered health systems that are prepared for pandemics, disease outbreaks, and climate change. Supply chain management and pharmaceutical systems strengthening are crucial to building these resilient health systems.

MSH President and CEO Marian W. Wentworth said, “This award creates incredible opportunities for lifesaving and world-changing impact. We are thrilled that USAID has recognized MSH’s thought leadership and implementation excellence in supply chain and pharmaceutical systems strengthening and our ability to bring together and lead impressive consortia of partners. We are excited to work with USAID and local leaders over the next decade to get medicines and technologies into the hands of the health workers and the people who need them to live healthy lives.”

MSH has assembled a consortium of specialized commercial and NGO partners—many based in Africa and Asia and all active in health, development, and/or supply chain work in low- and middle-income countries—that it may subcontract to as needed during task order implementation on solutions targeted to specific country challenges. The partners include long-standing USAID partner Deloitte Consulting LLP, together with Member Firm Deloitte South Africa; local innovation partners SwipeRX (formerly mClinica Pte Ltd.), U3 Advisors, Right to Care NPC/Right ePharmacy (Pty) Ltd., Reach Digital Health (formerly the Praekelt Foundation NPC), and PharmaRack Technologies Pvt. Ltd.; convening/behavior change partners and professional associations Ecumenical Pharmaceutical Network, Africa Healthcare Federation, and ideas42; learning institutions Cranfield University, Empower School of Health LLP, Kwame Nkrumah University of Science and Technology, Boston University, University of Washington, and International Law Institute – Center for Legal Excellence; and technology partners Mezzanine Ware RF (PTY) Ltd., Zipline International Inc., and Carahsoft Technology Corporation (Google).

To learn more about MSH’s current work in pharmaceutical systems strengthening and supply chain management, read about our global Medicines, Technologies, and Pharmaceutical Services program and our supply chain work in Uganda, Madagascar, and Ukraine, where the organization recently won a prestigious global supply chain prize.